Ninety One North America, Inc. Johnson & Johnson Transaction History

Ninety One North America, Inc.

$2.06 Billion
Q1 2024

A detailed history of Ninety One North America, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Ninety One North America, Inc. holds 352,739 shares of JNJ stock, worth $54.6 Million. This represents 2.71% of its overall portfolio holdings.

Number of Shares

352,739

Previous 363,893 3.07%

Holding current value

$54.6 Million

Previous $57 Million 2.17%

% of portfolio

2.71%

Previous 2.79%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$155.22 - $162.74 $1.73 Million - $1.82 Million	-11,154 Reduced 3.07%	352,739 $55.8 Million
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $10.3 Million - $11.2 Million	-70,679 Reduced 16.26%	363,893 $57 Million
Q3 2023 Oct 10, 2023	SELL	$155.75 - $174.48 $6.17 Million - $6.92 Million	-39,635 Reduced 8.36%	434,572 $67.7 Million
Q2 2023 Jul 19, 2023	SELL	$154.35 - $166.11 $574,490 - $618,261	-3,722 Reduced 0.78%	474,207 $78.5 Million
Q1 2023 Apr 28, 2023	SELL	$151.05 - $180.26 $153,013 - $182,603	-1,013 Reduced 0.21%	477,929 $74.1 Million

Q4 2022 Feb 07, 2023	SELL	$160.2 - $179.79 $7.74 Million - $8.69 Million	-48,310 Reduced 9.16%	478,942 $84.6 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $1.5 Million - $1.67 Million	-9,321 Reduced 1.74%	527,252 $86.1 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $4.21 Million - $4.66 Million	25,045 Added 4.9%	536,573 $95.2 Million
Q1 2022 Apr 27, 2022	BUY	$158.14 - $179.59 $2.65 Million - $3.01 Million	16,735 Added 3.38%	511,528 $90.7 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $15.7 Million - $17.4 Million	100,611 Added 25.52%	494,793 $84.6 Million
Q3 2021 Nov 02, 2021	BUY	$161.5 - $179.47 $5.16 Million - $5.74 Million	31,972 Added 8.83%	394,182 $63.7 Million
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $12.5 Million - $13.4 Million	78,449 Added 27.65%	362,210 $59.7 Million
Q1 2021 May 07, 2021	SELL	$153.07 - $170.48 $722,949 - $805,177	-4,723 Reduced 1.64%	283,761 $46.6 Million
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $18.1 Million - $20.7 Million	131,766 Added 84.08%	288,484 $45.4 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $9.91 Million - $10.9 Million	70,565 Added 81.91%	156,718 $23.3 Million
Q2 2020 Aug 20, 2020	BUY	$128.81 - $155.51 $5.12 Million - $6.18 Million	39,713 Added 85.51%	86,153 $12.1 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $19 Million - $23 Million	-147,773 Reduced 76.09%	46,440 $6.77 Million
Q1 2020 May 12, 2020	BUY	$111.14 - $153.99 $16.4 Million - $22.8 Million	147,773 Added 318.2%	194,213 $25.5 Million
Q4 2019 Feb 07, 2020	BUY	$127.5 - $146.44 $336,090 - $386,015	2,636 Added 6.02%	46,440 $6.77 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $174,048 - $194,873	-1,371 Reduced 3.03%	43,804 $5.67 Million
Q2 2019 Jul 30, 2019	SELL	$131.15 - $144.24 $862,573 - $948,666	-6,577 Reduced 12.71%	45,175 $6.29 Million
Q1 2019 Apr 24, 2019	BUY	$125.72 - $139.79 $422,922 - $470,253	3,364 Added 6.95%	51,752 $7.23 Million
Q4 2018 Feb 08, 2019	SELL	$122.84 - $147.84 $3.82 Million - $4.6 Million	-31,099 Reduced 39.12%	48,388 $6.24 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $1.05 Million - $1.23 Million	-8,596 Reduced 9.76%	79,487 $11 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $741,832 - $818,624	6,213 Added 7.59%	88,083 $10.7 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $5.48 Million - $6.49 Million	43,833 Added 115.24%	81,870 $10.5 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $2.84 Million - $3.1 Million	21,610 Added 131.55%	38,037 $5.32 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $2.13 Million - $2.22 Million	16,427	16,427 $2.14 Million

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One North America, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ninety One North America, Inc. with notifications on news.

Account

Ninety One North America, Inc. Johnson & Johnson Transaction History